Sort
15,273 grants matching “antimicrobial resistance”
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
$1,403,884George Louis Drusano · University Of Florida · R01 · FY2024 · AI
Mechanisms Of Drug-induced Toxicities
$1,402,533Lance R Pohl · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Medication Development for the Treatment of Alcohol Use Disorder
$1,401,264Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2023 · AA
Deep Learning Based Pharmacokinetic Model for Vancomycin
$1,400,490Masayuki Nigo · Methodist Hospital Research Institute · R01 · FY2025 · AI
FilmArray Direct: Rapid Diagnosis of Antimicrobial-Resistant Pathogens from Blood
$1,400,168Andrew Hemmert · Biofire Diagnostics, Llc · R01 · FY2015 · AI
GH16-006: Conducting Communicable Disease Research in Kenya
$1,400,000M Kariuki Njenga · Washington State University · U01 · FY2016 · GH
Collaborative Research: URoL:ASC: Using the Rules of Antibiotic Resistance Development to Inform Wastewater Mitigation Strategies
$1,400,000Diana S Aga · Suny At Buffalo · · FY2023 · BIO
Granulysin Derived Immunotherapeutics for Biodefense
$1,398,061Carol A. Clayberger · Stanford University · U19 · FY2006 · AI
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES
$1,397,685Karen Kotloff · University Of Maryland Baltimore · N01 · FY2017 · AI
AI-3 Inhibitors as treatment for bacterial infections
$1,396,328Vanessa Sperandio · Ut Southwestern Medical Center · U01 · FY2010 · AI
Granulysin Derived Immunotherapeutics for Biodefense
$1,394,377Elizabeth D Mellins · Stanford University · U19 · FY2007 · AI
Improving empiric therapy in ambulatory care
$1,394,124Jessina C McGregor · Oregon State University · R01 · FY2014 · HS
Granulysin Derived Immunotherapeutics for Biodefense
$1,393,965Stanford University · U19 · FY2005 · AI
AI-3 Inhibitors as treatment for bacterial infections
$1,389,957Vanessa Sperandio · Ut Southwestern Medical Center · U01 · FY2008 · AI
Early Antipseudomonal Therapy in Cystic Fibrosis
$1,388,177Seattle Children'S Hospital · U01 · FY2005 · HL
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform
$1,383,090Aaron R. Hawkins · Brigham Young University · R01 · FY2015 · AI
Molecular mechanisms of immune evasion in Staphylococcus aureus
$1,382,510Michael Otto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Medication Development for the Treatment of Alcohol Use Disorder
$1,379,570Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2024 · AA
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
$1,378,141Deborah T Hung · Broad Institute, Inc. · U19 · FY2020 · AI
Epithelial Genes in Allergic Inflammation
$1,376,302Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2017 · AI
AI-3 Inhibitors as treatment for bacterial infections
$1,372,064Vanessa Sperandio · Ut Southwestern Medical Center · U01 · FY2009 · AI
Technology development for point-of-care detection and antimicrobial susceptibility testing of Neisseria gonorrhoeae
$1,369,638Tza-Huei Jeff Wang · Johns Hopkins University · R01 · FY2018 · AI
Task V05: Manufacture of E. Coli Master Cell Banks for Staphylococcus aureus
$1,366,000Andreas Neubert · Idt Biologika Gmbh · N01 · FY2019 · AI
Structural Genomics Centers for Infectious Diseases
$1,365,852Karla Fullner Satchell · Northwestern University At Chicago · N01 · FY2020 · AI
International Research in Cambodia: Tropical Medicine and Vector Research
$1,364,178Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI